Overview

GF Securities is hosting its first GF Securities Life Sciences Investment Conference in Guangzhou on July 3-4, 2017.  This premier event is the only investment event held in conjunction with the highly-regarded 10th China Biosciences Annual Conference, which will feature Dr. Xiaodong Wang, BeiGene co-founder and AAS and CAS Fellow, as speakers (separate registration required). 

 

GF Securities Life Sciences Investment Conference (GFIC2017) attendees will have the chance to interact with nearly 100 listed Chinese life science companies, with a total market cap exceeding 900 billion USD.  These companies have a strong desire to invest in or acquire China and US/EU-based companies, in-license novel technologies, or partner to bring products to China.  There will also be a road show of invited companies presenting their novel technologies and products.  Industry and regulatory experts including Rogers Luo, GM of Gilead China, and Dr. Richard Myers, Hudsonalpha Institute President and former Chair of Department of Genetics, Stanford University School of Medicine, will present updates on the rapid evolution of the industry, including cross-border investment and the China market. 

 

Please join us for this unique opportunity to meet with leaders of the life science industry in China, as well as up-coming entrepreneurs and active investors at the first GF Securities Life Sciences Investment Conference in Guangzhou on July 3-4, 2017.

 

Hosted by: GF Securities
Co-organized by: GF XINDE Investment Management, Bay City Capital and ChinaBio® Group